cyclosporine has been researched along with Genetic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dias, A; Figueiredo, A; Nunes, P; Serrão, T | 1 |
| Abdel-Azim, H; Crooks, GM; Kapoor, N; Khazal, S; Kohn, DB; Mahadeo, KM; Shah, AJ; Zhao, Q | 1 |
2 other study(ies) available for cyclosporine and Genetic Diseases
| Article | Year |
|---|---|
An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma.
Topics: Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Female; Genetic Diseases, Inborn; Glucocorticoids; Hepatomegaly; Herpesvirus 4, Human; Hospitalization; Humans; Immunoglobulins, Intravenous; Infant; Intensive Care Units; Lymphohistiocytosis, Hemophagocytic; Severity of Illness Index; Splenomegaly; Syndrome | 2015 |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Gene Expression; Genetic Diseases, Inborn; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Myeloablative Agonists; Pilot Projects; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2015 |